Tibet Rhodiola Pharmaceutical Holding Co.,Ltd.’s Net Profit Rose 76.2% in 2022

Tibet Rhodiola Pharmaceutical Holding Co.,Ltd. (西藏诺迪康药业股份有限公司) (600211.SH) reported a net profit of 375.3 million yuan in 2022, up 76.2% year-on-year.

Meanwhile, the company posted 2.6 billion yuan in revenue, up 19.5% year-on-year.

At the end of the reporting period, it had 4.1 billion yuan in total assets and 1.1 billion yuan in total liabilities, with a liability-to-asset ratio of 26.1%.